» Articles » PMID: 1376744

Regulation of Rat Pulmonary Artery Endothelial Cell Transforming Growth Factor-beta Production by IL-1 Beta and Tumor Necrosis Factor-alpha

Overview
Journal J Immunol
Date 1992 Jul 1
PMID 1376744
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies suggest that transforming growth factor-beta (TGF-beta) production is up-regulated at sites of tissue injury, inflammation and repair, or fibrosis. Endothelial cells represent a potentially important in vivo source of TGF-beta; however, the identity of endogenous modulators of TGF-beta production by these cells remains unclear. To address this issue, the effects of the cytokines, IL-1 beta, and TNF-alpha on TGF-beta production by rat pulmonary artery endothelial cells were examined. Conditioned media from cells treated with 0 to 20 ng/ml IL-1 beta and/or TNF-alpha were assayed for TGF-beta activity using a mink lung epithelial cell line. The results show that rat pulmonary artery endothelial cells secreted undetectable amounts of active TGF-beta in the absence of cytokines. However, upon acidification of the conditioned media before assay, a time-dependent increase in TGF-beta activity was noted in media from both untreated and cytokine-treated cells. However, both IL-1 beta and TNF-alpha treatment caused the secretion of significantly greater amounts of TGF-beta activity than control cells, in a dose-dependent manner, with maximal response obtained at cytokine doses of greater than 10 ng/ml. At equivalent doses of cytokine tested, the magnitude of the response was significantly greater with IL-1 beta. These responses were paralleled by increases in steady state mRNA levels for TGF-beta 1. Addition of both cytokines resulted in a synergistic response. Synergism with IL-1 beta was also noted with the fibrogenic agent bleomycin. Kinetic studies indicated that a minimum of 4 h of treatment with either IL-1 beta or TNF-alpha was required for detection of significant increases in either secreted TGF-beta activity or steady state TGF-beta 1 mRNA levels. Thus, endothelial cells could play a role in various TGF-beta-dependent processes in vivo, in situations wherein IL-1 beta and/or TNF-alpha may be present at comparable concentrations.

Citing Articles

Pain improvement in Camurati-Engelmann disease after anti-TNFα therapy.

Moreira S, Cunha B, Jesus N, Santos L BMJ Case Rep. 2017; 2017.

PMID: 29184006 PMC: 5720334. DOI: 10.1136/bcr-2017-221760.


Hirsutella sinensis mycelium attenuates bleomycin-induced pulmonary inflammation and fibrosis in vivo.

Huang T, Lai H, Ko Y, Ojcius D, Lan Y, Martel J Sci Rep. 2015; 5:15282.

PMID: 26497260 PMC: 4620496. DOI: 10.1038/srep15282.


Increased serum and musculotendinous fibrogenic proteins following persistent low-grade inflammation in a rat model of long-term upper extremity overuse.

Gao H, Fisher P, Lambi A, Wade C, Barr-Gillespie A, Popoff S PLoS One. 2013; 8(8):e71875.

PMID: 24015193 PMC: 3756034. DOI: 10.1371/journal.pone.0071875.


Pentoxifylline improves liver regeneration through down-regulation of TNF-α synthesis and TGF-β1 gene expression.

Martino R, Coelho A, Kubrusly M, Leitao R, Sampietre S, Machado M World J Gastrointest Surg. 2012; 4(6):146-51.

PMID: 22816029 PMC: 3400043. DOI: 10.4240/wjgs.v4.i6.146.


IL-1β promotes TGF-β1 and IL-2 dependent Foxp3 expression in regulatory T cells.

Ganesh B, Bhattacharya P, Gopisetty A, Sheng J, Vasu C, Prabhakar B PLoS One. 2011; 6(7):e21949.

PMID: 21779356 PMC: 3136935. DOI: 10.1371/journal.pone.0021949.